SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Apr 2023 Evaluate
The March 2023 quarter revenue stood at Rs. 1184.90 millions, up 14.15% as compared to Rs. 1038.00 millions during the corresponding quarter last year.A comparatively good net profit growth of 37.63% to Rs. 103.50 millions was reported for the quarter ended March 2023 compared to Rs. 75.20 millions of previous same quarter.The company reported a good operating profit of 177.50 millions compared to 147.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1184.90 1038.00 14.15 5128.10 4401.60 16.51 5128.10 4401.60 16.51
Other Income 18.40 12.60 46.03 48.00 29.90 60.54 48.00 29.90 60.54
PBIDT 177.50 147.70 20.18 1074.90 893.50 20.30 1074.90 893.50 20.30
Interest 0.50 0.60 -16.67 3.10 5.20 -40.38 3.10 5.20 -40.38
PBDT 177.00 147.10 20.33 1071.80 888.30 20.66 1071.80 888.30 20.66
Depreciation 38.90 37.80 2.91 155.00 156.60 -1.02 155.00 156.60 -1.02
PBT 138.10 109.30 26.35 916.80 731.70 25.30 916.80 731.70 25.30
TAX 34.60 34.10 1.47 240.40 216.90 10.83 240.40 216.90 10.83
Deferred Tax -2.30 -6.90 -66.67 -3.10 -10.70 -71.03 -3.10 -10.70 -71.03
PAT 103.50 75.20 37.63 676.40 514.80 31.39 676.40 514.80 31.39
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 14.98 14.23 5.28 20.96 20.30 3.26 20.96 20.30 3.26

RPG Life Sciences Share Price

2015.65 -10.20 (-0.50%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×